Abstract
We analyzed the in vivo tumor regression activity of high molecular mass poly-γ-glutamate (γ-PGA) from Bacillus subtilis sups. chungkookjang. C57BL/6 mice were orally administered 10-, 100-, or 2000-kDa γ-PGA or β-glucan (positive control), and antitumor immunity was examined. Our results revealed higher levels of NK cell-mediated cytotoxicity and IFN-γ secretion in mice treated with higher molecular mass γ-PGA (2000 kDa) vs those treated with lower molecular mass γ-PGA (10 or 100 kDa) or β-glucan. We then examined the effect of oral administration of 10- or 2000-kDa γ-PGA on protection against B16 tumor challenge in C57BL/6 mice. Mice receiving high molecular mass γ-PGA (2000 kDa) showed significantly smaller tumor sizes following challenge with the MHC class I-down-regulated tumor cell lines, B16 and TC-1 P3 (A15), but not with TC-1 cells, which have normal MHC class I expression. Lastly, we found that γ-PGA-induced antitumor effect was decreased by in vivo depletion of NK cells using mAb PK136 or anti-asialo GM1 Ab, and that was completely blocked in NK cell-deficient B6 beige mice or IFN-γ knockout mice. Taken together, we demonstrated that oral administration of high molecular mass γ-PGA (2000 kDa) generated significant NK cell-mediated antitumor activity in mice bearing MHC class I-deficient tumors.
| Original language | English |
|---|---|
| Pages (from-to) | 775-780 |
| Number of pages | 6 |
| Journal | Journal of Immunology |
| Volume | 179 |
| Issue number | 2 |
| Publication status | Published - 2007 Jul 15 |
Fingerprint
ASJC Scopus subject areas
- Immunology
Cite this
Oral administration of high molecular mass poly-γ-glutamate induces NK cell-mediated antitumor immunity. / Kim, Tae Woo; Tae, Young Lee; Hyun, Cheol Bae; Jeong, Ho Hahm; Yang, Hyun Kim; Park, Chung; Tae, Heung Kang; Chul, Joong Kim; Moon, Hee Sung; Poo, Haryoung.
In: Journal of Immunology, Vol. 179, No. 2, 15.07.2007, p. 775-780.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Oral administration of high molecular mass poly-γ-glutamate induces NK cell-mediated antitumor immunity
AU - Kim, Tae Woo
AU - Tae, Young Lee
AU - Hyun, Cheol Bae
AU - Jeong, Ho Hahm
AU - Yang, Hyun Kim
AU - Park, Chung
AU - Tae, Heung Kang
AU - Chul, Joong Kim
AU - Moon, Hee Sung
AU - Poo, Haryoung
PY - 2007/7/15
Y1 - 2007/7/15
N2 - We analyzed the in vivo tumor regression activity of high molecular mass poly-γ-glutamate (γ-PGA) from Bacillus subtilis sups. chungkookjang. C57BL/6 mice were orally administered 10-, 100-, or 2000-kDa γ-PGA or β-glucan (positive control), and antitumor immunity was examined. Our results revealed higher levels of NK cell-mediated cytotoxicity and IFN-γ secretion in mice treated with higher molecular mass γ-PGA (2000 kDa) vs those treated with lower molecular mass γ-PGA (10 or 100 kDa) or β-glucan. We then examined the effect of oral administration of 10- or 2000-kDa γ-PGA on protection against B16 tumor challenge in C57BL/6 mice. Mice receiving high molecular mass γ-PGA (2000 kDa) showed significantly smaller tumor sizes following challenge with the MHC class I-down-regulated tumor cell lines, B16 and TC-1 P3 (A15), but not with TC-1 cells, which have normal MHC class I expression. Lastly, we found that γ-PGA-induced antitumor effect was decreased by in vivo depletion of NK cells using mAb PK136 or anti-asialo GM1 Ab, and that was completely blocked in NK cell-deficient B6 beige mice or IFN-γ knockout mice. Taken together, we demonstrated that oral administration of high molecular mass γ-PGA (2000 kDa) generated significant NK cell-mediated antitumor activity in mice bearing MHC class I-deficient tumors.
AB - We analyzed the in vivo tumor regression activity of high molecular mass poly-γ-glutamate (γ-PGA) from Bacillus subtilis sups. chungkookjang. C57BL/6 mice were orally administered 10-, 100-, or 2000-kDa γ-PGA or β-glucan (positive control), and antitumor immunity was examined. Our results revealed higher levels of NK cell-mediated cytotoxicity and IFN-γ secretion in mice treated with higher molecular mass γ-PGA (2000 kDa) vs those treated with lower molecular mass γ-PGA (10 or 100 kDa) or β-glucan. We then examined the effect of oral administration of 10- or 2000-kDa γ-PGA on protection against B16 tumor challenge in C57BL/6 mice. Mice receiving high molecular mass γ-PGA (2000 kDa) showed significantly smaller tumor sizes following challenge with the MHC class I-down-regulated tumor cell lines, B16 and TC-1 P3 (A15), but not with TC-1 cells, which have normal MHC class I expression. Lastly, we found that γ-PGA-induced antitumor effect was decreased by in vivo depletion of NK cells using mAb PK136 or anti-asialo GM1 Ab, and that was completely blocked in NK cell-deficient B6 beige mice or IFN-γ knockout mice. Taken together, we demonstrated that oral administration of high molecular mass γ-PGA (2000 kDa) generated significant NK cell-mediated antitumor activity in mice bearing MHC class I-deficient tumors.
UR - http://www.scopus.com/inward/record.url?scp=34548759204&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548759204&partnerID=8YFLogxK
M3 - Article
C2 - 17617566
AN - SCOPUS:34548759204
VL - 179
SP - 775
EP - 780
JO - Journal of Immunology
JF - Journal of Immunology
SN - 0022-1767
IS - 2
ER -